More than 300 doctors participated in this conference.

The second day of the conference was dedicated to the clinical analysis of the cases of a nonstandard course of endocrine diseases.

The reports of the employees of the Department of Endocrine Disease Pharmacotherapy attracted a vivid interest of practitioners in the hall.

Doctor of Medical Science Kravchun Nonna Alexandrovna, the head of the Department of Endocrine Pathology presented a seemingly ordinary case of the course of type II diabetes mellitus with a concomitant obesity.

A main emphasis in the report of Kravchun N.A. was laid on the modern choice of the rational pharmacotherapy in similar cases and she also shared the best practice of the department in this question.

The products of Megacom Company Glianov (glimepiride) and Cefamadar proved to be effective in the therapy of type II diabetes mellitus in patients with obesity.

Glianov (glimepiride) showed a significant decrease in glucose with a normalization of “blood sugar”.

Cefamadar was effectively used for the purpose of the effective correction of obesity with underlying type II diabetes mellitus.